TAKEDA PHARMACEUTICAL CO LTDTAKEDA PHARMACEUTICAL CO LTDTAKEDA PHARMACEUTICAL CO LTD

TAKEDA PHARMACEUTICAL CO LTD

No trades
See on Supercharts
Next report date
Report period
EPS estimate
Revenue estimate
Market capitalization
‪40.18 B‬EUR
‪882.16 M‬EUR
‪26.11 B‬EUR
‪1.53 B‬
Beta (1Y)
0.79

About TAKEDA PHARMACEUTICAL CO LTD

CEO
Christophe Weber
Headquarters
Osaka
Website
Employees (FY)
‪49.28 K‬
Founded
1781
ISIN
JP3463000004
FIGI
BBG000BYJTV4
Takeda Pharmaceutical Co., Ltd. engages in the research and development, manufacture, import and export sale, and marketing of pharmaceutical drugs. It operates through the following segments: Prescription Drug, Consumer Healthcare, and Other. The Prescription Drugs segment includes the manufacture and sale of pharmaceutical products. The Consumer Healthcare segment includes the manufacture and sale of OTC drugs and quasi-drugs. The Other segment includes manufacture and sale of reagents, clinical diagnostics, and chemical products. The company was founded by Takeda Chobei on June 12, 1781 and is headquartered in Osaka, Japan.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬

See all ideas 

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of TKD is 25.08 EUR — it has decreased by 0.44% in the past 24 hours. Watch TAKEDA PHARMACEUTICAL CO LTD stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on GETTEX exchange TAKEDA PHARMACEUTICAL CO LTD stocks are traded under the ticker TKD.
TKD stock has risen by 0.80% compared to the previous week, the month change is a 5.16% rise, over the last year TAKEDA PHARMACEUTICAL CO LTD has showed a 10.72% decrease.
We've gathered analysts' opinions on TAKEDA PHARMACEUTICAL CO LTD future price: according to them, TKD price has a max estimate of 33.15 EUR and a min estimate of 24.86 EUR. Watch TKD chart and read a more detailed TAKEDA PHARMACEUTICAL CO LTD stock forecast: see what analysts think of TAKEDA PHARMACEUTICAL CO LTD and suggest that you do with its stocks.
TKD reached its all-time high on Mar 7, 2006 with the price of 416.21 EUR, and its all-time low was 22.00 EUR and was reached on Mar 9, 2009. View more price dynamics on TKD chart.
See other stocks reaching their highest and lowest prices.
TKD stock is 1.12% volatile and has beta coefficient of 0.79. Track TAKEDA PHARMACEUTICAL CO LTD stock price on the chart and check out the list of the most volatile stocks — is TAKEDA PHARMACEUTICAL CO LTD there?
Today TAKEDA PHARMACEUTICAL CO LTD has the market capitalization of ‪40.08 B‬, it has increased by 0.75% over the last week.
Yes, you can track TAKEDA PHARMACEUTICAL CO LTD financials in yearly and quarterly reports right on TradingView.
TAKEDA PHARMACEUTICAL CO LTD is going to release the next earnings report on Jul 31, 2024. Keep track of upcoming events with our Earnings Calendar.
TKD earnings for the last quarter are −0.01 EUR per share, whereas the estimation was 0.01 EUR resulting in a −290.04% surprise. The estimated earnings for the next quarter are 0.23 EUR per share. See more details about TAKEDA PHARMACEUTICAL CO LTD earnings.
TAKEDA PHARMACEUTICAL CO LTD revenue for the last quarter amounts to ‪6.43 B‬ EUR, despite the estimated figure of ‪5.55 B‬ EUR. In the next quarter, revenue is expected to reach ‪6.32 B‬ EUR.
TKD net income for the last quarter is ‪−18.48 M‬ EUR, while the quarter before that showed ‪678.82 M‬ EUR of net income which accounts for −102.72% change. Track more TAKEDA PHARMACEUTICAL CO LTD financial stats to get the full picture.
TAKEDA PHARMACEUTICAL CO LTD dividend yield was 4.49% in 2023, and payout ratio reached 204.15%. The year before the numbers were 4.14% and 88.11% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Jul 24, 2024, the company has ‪49.28 K‬ employees. See our rating of the largest employees — is TAKEDA PHARMACEUTICAL CO LTD on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. TAKEDA PHARMACEUTICAL CO LTD EBITDA is ‪7.35 B‬ EUR, and current EBITDA margin is 29.51%. See more stats in TAKEDA PHARMACEUTICAL CO LTD financial statements.
Like other stocks, TKD shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade TAKEDA PHARMACEUTICAL CO LTD stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So TAKEDA PHARMACEUTICAL CO LTD technincal analysis shows the buy rating today, and its 1 week rating is neutral. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating TAKEDA PHARMACEUTICAL CO LTD stock shows the sell signal. See more of TAKEDA PHARMACEUTICAL CO LTD technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.